M.E. Allison & Co
ABBV icon

M.E. Allison & Co’s AbbVie ABBV Stock Holding History

M.E. Allison & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$625K Hold
2,390
– – 0.35% 79
2026
Q2 		$601K Sell
2,390
-50
-2% -$10.8K 0.35% 79
2026
Q1 		$520K Hold
2,440
– – 0.34% 78
2025
Q4 		$558K Sell
2,440
-50
-2% -$11.4K 0.38% 69
2025
Q3 		$577K Sell
2,490
-19
-0.8% -$3.87K 0.4% 66
2025
Q2 		$466K Buy
2,509
+1,110
+79% +$206K 0.37% 68
2025
Q1 		$293K Buy
+1,399
New +$272K 0.29% 104

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Ferguson Wellman Capital Management
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

M.E. Allison & Co's ABBV Position: Q3 2026 in Review

M.E. Allison & Co held its AbbVie (ABBV) position steady in Q3 2026 at 2,390 shares worth $625K. The position accounts for 0.35% of the portfolio, ranked #79.

M.E. Allison & Co first reported a position in ABBV in Q1 2025 and has held it in 7 quarters since. 1,083 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • M.E. Allison & Co held 2,390 shares of AbbVie worth $625K as of Q3 2026.
  • M.E. Allison & Co left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.35% of M.E. Allison & Co's portfolio in Q3 2026, its #79 holding.
  • M.E. Allison & Co first reported a position in AbbVie in Q1 2025 and has held it in 7 quarters since.
  • 1,083 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on M.E. Allison & Co's 13F filing for Q3 2026, filed 9 Oct 2026.